Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.

Jain P, Zhang S, Kanagal-Shamanna R, Ok CYoung, Nomie K, Gonzalez GNogueras, Gonzalez-Pagan O, Hill HA, Lee HJu, Fayad L, et al. Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. Blood Adv. 2020;4(6):1038-1050.